Hims & Hers Declines - How The GLP-1 Market Shift Affects Growth
Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...
Hosted on MSN1h
Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update
Hims & Hers Health Inc. (HIMS) stock tumbled over 25% on Friday, extending losses in after-hours trading after the U.S. Food ...
Hosted on MSN16h
Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should ...
1 Stock to Buy, 1 Stock to Sell This Week: Nvidia, Lowe’s
PCE inflation data, Fed speakers, more earnings will be in focus this week. • Nvidia’s robust performance in the burgeoning AI space and strong guidance position it as a clear buy. • Lowe’s’ struggles ...
Analysts Conflicted on These Healthcare Names: Halozyme (HALO), Walgreens Boots Alliance (WBA) and Axsome Therapeutics (AXSM)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Halozyme (HALO – Research Report), Walgreens Boots Alliance ...
Barron's7h
Barron’s Stock Picks
Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...
Yahoo Finance12h
Yahoo Finance – stock market live, quotes, business and finance news
Palantir stock fell more than 10% Wednesday following a report the Trump administration is planning deep cuts to the defense budget. The "DOGE" efficiency commission has begun posting details of the ...